Do you want to read an article? Please log in or register.
Clinical Outcomes to Exercise Training in Type 1 Diabetes: A Systematic Review and Meta-Analysis
Diabetes - GeneralType 1 DiabetesGlycemic Control
Related content
COMMENTED
Type 2 Diabetes
Effect of SGLT2 inhibitors on cardiovascular, renal and safety outcomes in patients with type 2 diabetes mellitus and chronic kidney disease: a systematic review and meta-analysis
Diabetes Obes Metab.
Toyama T, Neuen BL, Jun M, Ohkuma T, Neal B, Jardine M, Heerspink HL, Wong MG, Ninomiya T, Wada T, Perkovic V
doi: 10.1111/dom.
COMMENTED
Type 2 Diabetes
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
Lancet Diabetes Endocrinol.
Kristensen SL, Rørth R, Jhund PS, Docherty KF, Sattar N, Preiss D, Køber L, Petrie MC, McMurray JJV
doi: 10.1016/S2213-8587(19)30249-9.
Diabetes - GeneralType 1 DiabetesGlycemic Control
Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials
Lancet Diabetes Endocrinol.
Weisman A, Bai JW, Cardinez M, Kramer CK, Perkins BA
doi: 10.1016/
Type 1 Diabetes
Systematic Literature Review and Network Meta-Analysis of SGLT Inhibitors versus Metformin as Add-On to Insulin in Type 1 Diabetes
Diabetes Obes Metab.
Langford BE, Evans M, Haskins-Coulter T, O'Connor ME, Cant H, Eddowes LA, Edmonds C, Tank A
doi: 10.1111/dom.13863.
COMMENTED
Type 2 Diabetes
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
Lancet.
Zelniker TA, Wiviott SD, Raz I, Im K, Goodrich EL, Bonaca MP, Mosenzon O, Kato ET, Cahn A, Furtado RHM, Bhatt DL, Leiter LA, McGuire DK, Wilding JPH, Sabatine MS
doi: 10.1016/S0140-6736
Type 1 DiabetesGlycemic ControlPediatric Diabetes
Effect of early glycaemic control on HbA1c tracking and development of vascular complications after 5 years of childhood onset type 1 diabetes: Systematic Review and Meta-analysis
Pediatr Diabetes.
Mazarello Paes V, Barrett JK, Taylor-Robinson DC, Chesters H, Charalampopoulos D, Dunger DB, Viner RM6, Stephenson TJ
doi: 10.1111/pedi.12850.
COMMENTED
Type 2 Diabetes
Glucagon-like peptide 1 receptor agonists and sodium glucose co-transporter 2 inhibitors as combination therapy for type 2 diabetes. A systematic review and meta-analysis
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Diabetes Obes Metab.
Mantsiou C, Karagiannis T, Kakotrichi P, Malandris K, Avgerinos I, Liakos A, Apostolos Tsapas, Bekiari E
doi: 10.1111/dom.14108.
Type 2 Diabetes
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials
Lancet Diabetes Endocrinol
Sattar N, Lee MMY, Kristensen SL, Branch KRH, Del Prato S, Khurmi NS, Lam CSP, Lopes RD, McMurray JJV, Pratley RE, Rosenstock J, Gerstein HC
doi: 10.1016/S2213-8587(21)00203-5
COMMENTED
Type 1 Diabetes
Immune checkpoint inhibitor-induced Type 1 diabetes: a systematic review and meta-analysis
Diabet Med.
Akturk HK, Kahramangil D, Sarwal A, Hoffecker L, Murad MH, Michels AW
doi: 10.1111/dme.14050.